Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
ALTO vs REX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
ALTO vs REX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $351M | $1.60B |
| Revenue (TTM) | $918M | $651M |
| Net Income (TTM) | $13M | $50M |
| Gross Margin | 3.8% | 12.7% |
| Operating Margin | 0.8% | 8.6% |
| Forward P/E | 15.4x | 62.8x |
| Total Debt | $98M | $21M |
| Cash & Equiv. | $26M | $196M |
ALTO vs REX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Alto Ingredients, I… (ALTO) | 100 | 680.7 | +580.7% |
| REX American Resour… (REX) | 100 | 498.3 | +398.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALTO vs REX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALTO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.30, yield 0.4%
- Rev growth -4.9%, EPS growth 119.5%, 3Y rev CAGR -11.8%
- Lower volatility, beta 0.30, Low D/E 39.8%, current ratio 2.64x
REX is the clearest fit if your priority is long-term compounding.
- 464.7% 10Y total return vs ALTO's 6.8%
- 7.7% margin vs ALTO's 1.5%
- 6.7% ROA vs ALTO's 3.4%, ROIC 11.4% vs 1.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -4.9% revenue growth vs REX's -22.9% | |
| Value | Lower P/E (15.4x vs 62.8x) | |
| Quality / Margins | 7.7% margin vs ALTO's 1.5% | |
| Stability / Safety | Beta 0.30 vs REX's 0.36 | |
| Dividends | 0.4% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +427.8% vs REX's +147.6% | |
| Efficiency (ROA) | 6.7% ROA vs ALTO's 3.4%, ROIC 11.4% vs 1.9% |
ALTO vs REX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALTO vs REX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
REX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALTO and REX operate at a comparable scale, with $918M and $651M in trailing revenue. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to ALTO's 1.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $918M | $651M |
| EBITDAEarnings before interest/tax | $33M | $67M |
| Net IncomeAfter-tax profit | $13M | $50M |
| Free Cash FlowCash after capex | $9M | $18M |
| Gross MarginGross profit ÷ Revenue | +3.8% | +12.7% |
| Operating MarginEBIT ÷ Revenue | +0.8% | +8.6% |
| Net MarginNet income ÷ Revenue | +1.5% | +7.7% |
| FCF MarginFCF ÷ Revenue | +0.9% | +2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.9% | +0.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +149.1% | +2.9% |
Valuation Metrics
ALTO leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 28.4x trailing earnings, ALTO trades at a 4% valuation discount to REX's 29.5x P/E. On an enterprise value basis, ALTO's 12.8x EV/EBITDA is more attractive than REX's 16.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $351M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $423M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | 28.38x | 29.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.39x | 62.81x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.55x |
| EV / EBITDAEnterprise value multiple | 12.84x | 16.60x |
| Price / SalesMarket cap ÷ Revenue | 0.38x | 2.50x |
| Price / BookPrice ÷ Book value/share | 1.40x | 2.67x |
| Price / FCFMarket cap ÷ FCF | 40.58x | — |
Profitability & Efficiency
REX leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $6 for ALTO. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALTO's 0.40x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.0% | +7.7% |
| ROA (TTM)Return on assets | +3.4% | +6.7% |
| ROICReturn on invested capital | +1.9% | +11.4% |
| ROCEReturn on capital employed | +2.3% | +10.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.40x | 0.03x |
| Net DebtTotal debt minus cash | $72M | -$175M |
| Cash & Equiv.Liquid assets | $26M | $196M |
| Total DebtShort + long-term debt | $98M | $21M |
| Interest CoverageEBIT ÷ Interest expense | -0.93x | — |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $7,882 for ALTO. Over the past 12 months, ALTO leads with a +427.8% total return vs REX's +147.6%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs ALTO's 49.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +70.7% | +50.2% |
| 1-Year ReturnPast 12 months | +427.8% | +147.6% |
| 3-Year ReturnCumulative with dividends | +233.8% | +243.1% |
| 5-Year ReturnCumulative with dividends | -21.2% | +250.0% |
| 10-Year ReturnCumulative with dividends | +6.8% | +464.7% |
| CAGR (3Y)Annualised 3-year return | +49.5% | +50.8% |
Risk & Volatility
Evenly matched — ALTO and REX each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALTO is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than REX's 0.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 91.2% from its 52-week high vs ALTO's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.30x | 0.36x |
| 52-Week HighHighest price in past year | $5.99 | $53.36 |
| 52-Week LowLowest price in past year | $0.80 | $19.44 |
| % of 52W HighCurrent price vs 52-week peak | +75.8% | +91.2% |
| RSI (14)Momentum oscillator 0–100 | 61.1 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 204K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ALTO as "Buy" and REX as "Buy". Consensus price targets imply 23.3% upside for REX (target: $60) vs -22.9% for ALTO (target: $4). ALTO is the only dividend payer here at 0.37% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.50 | $60.00 |
| # AnalystsCovering analysts | 2 | 3 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | $0.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% |
REX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALTO leads in 1 (Valuation Metrics). 1 tied.
ALTO vs REX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ALTO or REX a better buy right now?
For growth investors, Alto Ingredients, Inc.
(ALTO) is the stronger pick with -4. 9% revenue growth year-over-year, versus -22. 9% for REX American Resources Corporation (REX). Alto Ingredients, Inc. (ALTO) offers the better valuation at 28. 4x trailing P/E (15. 4x forward), making it the more compelling value choice. Analysts rate Alto Ingredients, Inc. (ALTO) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALTO or REX?
On trailing P/E, Alto Ingredients, Inc.
(ALTO) is the cheapest at 28. 4x versus REX American Resources Corporation at 29. 5x. On forward P/E, Alto Ingredients, Inc. is actually cheaper at 15. 4x.
03Which is the better long-term investment — ALTO or REX?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.
0%, compared to -21. 2% for Alto Ingredients, Inc. (ALTO). Over 10 years, the gap is even starker: REX returned +464. 7% versus ALTO's +6. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALTO or REX?
By beta (market sensitivity over 5 years), Alto Ingredients, Inc.
(ALTO) is the lower-risk stock at 0. 30β versus REX American Resources Corporation's 0. 36β — meaning REX is approximately 20% more volatile than ALTO relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 40% for Alto Ingredients, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALTO or REX?
By revenue growth (latest reported year), Alto Ingredients, Inc.
(ALTO) is pulling ahead at -4. 9% versus -22. 9% for REX American Resources Corporation (REX). On earnings-per-share growth, the picture is similar: Alto Ingredients, Inc. grew EPS 119. 5% year-over-year, compared to -4. 9% for REX American Resources Corporation. Over a 3-year CAGR, REX leads at -6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALTO or REX?
REX American Resources Corporation (REX) is the more profitable company, earning 9.
1% net margin versus 1. 5% for Alto Ingredients, Inc. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus 0. 8% for ALTO. At the gross margin level — before operating expenses — REX leads at 14. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALTO or REX more undervalued right now?
On forward earnings alone, Alto Ingredients, Inc.
(ALTO) trades at 15. 4x forward P/E versus 62. 8x for REX American Resources Corporation — 47. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.
08Which pays a better dividend — ALTO or REX?
In this comparison, ALTO (0.
4% yield) pays a dividend. REX does not pay a meaningful dividend and should not be held primarily for income.
09Is ALTO or REX better for a retirement portfolio?
For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
36), +464. 7% 10Y return). Both have compounded well over 10 years (REX: +464. 7%, ALTO: +6. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALTO and REX?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.